Physician profile
Johnny Stackhouse
NPI 1952569626
$720.10
in general payments reported to CMS, 2019-2025
15 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $69.94 · 2021: $76.83 · 2022: $31.21 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $258.90 | 2021-2025 | Repatha, Otezla |
| Abbott Laboratories | $139.43 | 2025 | Proclaim |
| Neos Therapeutics, Lp | $67.29 | 2019-2020 | |
| Tris Pharma INC | $47.11 | 2019 | |
| Lilly USA, LLC | $36.77 | 2019-2021 | |
| Djo, LLC | $23.32 | 2021 | |
| Upsher-Smith Laboratories LLC | $23.18 | 2020 | |
| Novo Nordisk INC | $18.25 | 2020 | |
| Genentech USA, INC. | $18.22 | 2019 | |
| Bausch Health US, LLC | $17.39 | 2019 | |
| Merck Sharp & Dohme LLC | $15.67 | 2022 | |
| Ironshore Pharmaceuticals INC. | $15.54 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.01 | 2019 | |
| Pfizer INC. | $13.19 | 2019 | |
| Adlon Therapeutics L.P. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Stackhouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.